Cytotoxicity screenings
have identified
Plectranthus
plants as potential
sources of antitumor lead compounds. In this
work, several extracts from
Plectranthus madagascariensis
were prepared using different solvents (acetone, methanol, and supercritical
CO
2
) and extraction techniques (maceration, ultrasound-assisted,
and supercritical fluid extraction), and their chemical composition
was detailed using high-performance liquid chromatography with a diode
array detector. The cytotoxic activity of the major compounds identified,
namely, rosmarinic acid (
1
) and abietane diterpenes 7α,6β-dihydroxyroyleanone
(
2
), 7α-formyloxy-6β-hydroxyroyleanone (
3
), 7α-acetoxy-6β-hydroxyroyleanone (
4
), and coleon U (
5
), was evaluated in a battery of human
cancer cell lines, including breast (MDA-MB-231, MCF-7), colon (HCT116),
and lung (NCI-H460, NCI-H460/R) cancer, and also in healthy lung (MCR-5)
cells. Royleanone (
3
) was isolated for the first time
from
P. madagascariensis
, and its full
spectroscopic characterization (proton and carbon nuclear magnetic
resonance) was accomplished. A high selectivity for lung cancer cells
was observed for royleanones (
2
,
4
) with
selectivity indexes of 4.3 and 3.2, respectively. The observed results
combined with literature data allowed the establishment of important
structure–activity relationships for substituted royleanone
abietanes, such as the requirement for an electron-donating group
at positions 6 and/or 7 in the abietane skeleton, and an improved
cytotoxic effect for substituents with log
P
values
between 2 and 5.